Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 23, 2020

SELL
$7.14 - $16.86 $2,856 - $6,744
-400 Closed
0 $0
Q4 2019

Feb 05, 2020

BUY
$13.08 - $17.43 $5,232 - $6,972
400 New
400 $6,000
Q3 2019

Oct 18, 2019

SELL
$8.65 - $14.81 $3,460 - $5,924
-400 Closed
0 $0
Q2 2019

Aug 01, 2019

BUY
$7.1 - $11.62 $2,840 - $4,648
400 New
400 $5,000

Others Institutions Holding VRCA

About Verrica Pharmaceuticals Inc.


  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Coastal Investment Advisors, Inc. Portfolio

Follow Coastal Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.